Literature DB >> 23223359

Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

Eran Ophir1, Noga Or-Geva, Irina Gurevich, Orna Tal, Yaki Eidelstein, Elias Shezen, Raanan Margalit, Assaf Lask, Guy Shakhar, David Hagin, Esther Bachar-Lustig, Shlomit Reich-Zeliger, Andreas Beilhack, Robert Negrin, Yair Reisner.   

Abstract

Transplantation of T cell-depleted BM (TDBM) under mild conditioning, associated with minimal toxicity and reduced risk of GVHD, offers an attractive therapeutic option for patients with nonmalignant hematologic disorders and can mediate immune tolerance to subsequent organ transplantation. However, overcoming TDBM rejection after reduced conditioning remains a challenge. Here, we address this barrier using donorderived central memory CD8(+) T cells (Tcms), directed against third-party antigens. Our results show that fully allogeneic or (hostXdonor)F1-Tcm, support donor chimerism (> 6 months) in sublethally irradiated (5.5Gy) mice, without GVHD symptoms. Chimerism under yet lower irradiation (4.5Gy) was achieved by combining Tcm with short-term administration of low-dose Rapamycin. Importantly, this chimerism resulted in successful donor skin acceptance, whereas third-party skin was rejected. Tracking of host anti-donor T cells (HADTCs), that mediate TDBMT rejection, in a novel bioluminescence-imaging model revealed that Tcms both induce accumulation and eradicate HADTCs in the LNs,concomitant with their elimination from other organs, including the BM. Further analysis with 2-photon microcopy revealed that Tcms form conjugates with HADTCs, resulting in decelerated and confined movement of HADTCs within the LNs in an antigen-specific manner. Thus, anti-third-party Tcms support TDBMT engraftment under reduced-conditioning through lymph-node sequestration and deletion of HADTCs, offering a novel and potentially safe approach for attaining stable hematopoietic chimerism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223359      PMCID: PMC4467899          DOI: 10.1182/blood-2012-07-441493

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.

Authors:  Katia Perruccio; Fabiana Topini; Antonella Tosti; Alessandra Carotti; Teresa Aloisi; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Blood Cells Mol Dis       Date:  2007-11-05       Impact factor: 3.039

2.  CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Authors:  Oren Milstein; David Hagin; Assaf Lask; Shlomit Reich-Zeliger; Elias Shezen; Eran Ophir; Yaki Eidelstein; Ran Afik; Yaron E Antebi; Michael L Dustin; Yair Reisner
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

3.  Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells.

Authors:  Eran Ophir; Yaki Eidelstein; Ran Afik; Esther Bachar-Lustig; Yair Reisner
Journal:  Blood       Date:  2009-12-30       Impact factor: 22.113

4.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

Authors:  Joshua J Obar; Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2008-05-22       Impact factor: 31.745

Review 5.  Haploidentical hematopoietic transplantation: current status and future perspectives.

Authors:  Yair Reisner; David Hagin; Massimo F Martelli
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

6.  Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.

Authors:  Jung-Sik Kim; Jae-Il Lee; Jin-Young Shin; Su-Young Kim; Jun-Seop Shin; Jong-Hyung Lim; Hyoung-Soo Cho; Il-Hee Yoon; Ki-Hyun Kim; Sang-Joon Kim; Chung-Gyu Park
Journal:  Transplantation       Date:  2009-12-27       Impact factor: 4.939

Review 7.  Inducing mixed chimerism and transplantation tolerance through allogeneic bone marrow transplantation with costimulation blockade.

Authors:  Ines Pree; Thomas Wekerle
Journal:  Methods Mol Biol       Date:  2007

8.  T cell receptor-mediated activation of CD4+CD44hi T cells bypasses Bcl10: an implication of differential NF-kappaB dependence of naïve and memory T cells during T cell receptor-mediated responses.

Authors:  Hu Zeng; Yuhong Chen; Mei Yu; Liquan Xue; Xiang Gao; Stephan W Morris; Demin Wang; Renren Wen
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

9.  Induction of tolerance in organ recipients by hematopoietic stem cell transplantation.

Authors:  Eran Ophir; Yair Reisner
Journal:  Int Immunopharmacol       Date:  2009-01-16       Impact factor: 4.932

10.  Rac activation by the T-cell receptor inhibits T cell migration.

Authors:  Eva Cernuda-Morollón; Jaime Millán; Mark Shipman; Federica M Marelli-Berg; Anne J Ridley
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

View more
  10 in total

1.  The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Authors:  N Or-Geva; Y Reisner
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

2.  Central memory CD8+ T lymphocytes mediate lung allograft acceptance.

Authors:  Alexander Sasha Krupnick; Xue Lin; Wenjun Li; Ryuiji Higashikubo; Bernd H Zinselmeyer; Hollyce Hartzler; Kelsey Toth; Jon H Ritter; Mikhail Y Berezin; Steven T Wang; Mark J Miller; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 3.  Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.

Authors:  Y-J Chang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

4.  Towards 'off-the-shelf' genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells.

Authors:  N Or-Geva; R Gidron-Budovsky; L Radomir; Y Edelstein; A K Singh; R Sidlik-Muskatel; E Ophir; E Bachar-Lustig; Y Reisner
Journal:  Leukemia       Date:  2017-11-20       Impact factor: 11.528

5.  Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide.

Authors:  Franco Aversa; Esther Bachar-Lustig; Noga Or-Geva; Lucia Prezioso; Sabrina Bonomini; Ilenia Manfra; Alessandro Monti; Chiara Schifano; Yael Zlotnikov-Klionsky; Massimo F Martelli; Gabriella Sammarelli; Maria Sassi; Maurizio Soli; Silvia Giuliodori; Magda Benecchi; Nicola Giuliani; Frank Lohr; Silvia Pratissoli; Yair Reisner
Journal:  Blood Adv       Date:  2017-10-30

6.  Memory CD4+ T cells are suppressed by CD8+ regulatory T cells in vitro and in vivo.

Authors:  Xin Long; Qi Cheng; Huifang Liang; Jianping Zhao; Jian Wang; Wei Wang; Stephen Tomlinson; Lin Chen; Carl Atkinson; Bixiang Zhang; Xiaoping Chen; Peng Zhu
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

7.  A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells.

Authors:  Assaf Lask; Eran Ophir; Noga Or-Geva; Adva Cohen-Fredarow; Ran Afik; Yaki Eidelstein; Shlomit Reich-Zeliger; Bar Nathansohn; Matthias Edinger; Robert S Negrin; David Hagin; Yair Reisner
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

Review 8.  Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016.

Authors:  Monzr M Al Malki; Richard Jones; Qing Ma; Dean Lee; Yair Reisner; Jeffrey S Miller; Peter Lang; Suradej Hongeng; Parameswaran Hari; Samuel Strober; Jianhua Yu; Richard Maziarz; Domenico Mavilio; Denis-Claude Roy; Chiara Bonini; Richard E Champlin; Ephraim J Fuchs; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-12       Impact factor: 5.742

9.  Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells.

Authors:  Aloukick Kumar Singh; Elias Schetzen; Sandeep Kumar Yadav; Esther Bachar Lustig; Wei-Hsin Liu; Raj Kumar Yadav; Robert Peter Gale; Kathryn McGinnis; Yair Reisner
Journal:  Bone Marrow Transplant       Date:  2021-03-03       Impact factor: 5.174

Review 10.  Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.

Authors:  Asaf Yanir; Ansgar Schulz; Anita Lawitschka; Stefan Nierkens; Matthias Eyrich
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.